Development and validation of a clinical scoring system for predicting risk of HCC in asymptomatic individuals seropositive for anti-HCV antibodies.

Development and validation of a clinical scoring system for predicting risk of HCC in asymptomatic individuals seropositive for anti-HCV antibodies.

Item
http://www.wikidata.org/entity/Q33572715
Molecular prognostic prediction in liver cirrhosisAPASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.Personalized management of hepatocellular carcinoma based on molecular information: future prospects.Dynamic prediction of risk of liver-related outcomes in chronic hepatitis C using routinely collected data.The Hepatitis Viral Status in Patients With Hepatocellular Carcinoma: a Study of 3843 Patients From Taiwan Liver Cancer NetworkGenetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment.Tailored algorithms for hepatocellular carcinoma surveillance: Is one-size-fits-all strategy outdated?Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study.Diabetes, hepatocellular carcinoma, and mortality in hepatitis C-infected patients: A population-based cohort study.Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir).Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population.Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.Predicting Hepatitis B Virus (HBV) Surface Antigen Seroclearance in HBV e Antigen-Negative Patients With Chronic Hepatitis B: External Validation of a Scoring System.
P2860

Development and validation of a clinical scoring system for predicting risk of HCC in asymptomatic individuals seropositive for anti-HCV antibodies.

Item
http://www.wikidata.org/entity/Q33572715
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Development and validation of ...... itive for anti-HCV antibodies.
@ast
Development and validation of ...... itive for anti-HCV antibodies.
@en
Development and validation of ...... itive for anti-HCV antibodies.
@nl
type
label
Development and validation of ...... itive for anti-HCV antibodies.
@ast
Development and validation of ...... itive for anti-HCV antibodies.
@en
Development and validation of ...... itive for anti-HCV antibodies.
@nl
prefLabel
Development and validation of ...... itive for anti-HCV antibodies.
@ast
Development and validation of ...... itive for anti-HCV antibodies.
@en
Development and validation of ...... itive for anti-HCV antibodies.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Development and validation of ...... itive for anti-HCV antibodies.
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0094760
P407
P433
P478
P50
P577
P5875
P698
P921
P932